QA: Urogen Pharma Ltd in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001668243_2024_Urogen_Pharma_Ltd.pdf

Logs

Graph

Absolute values for 0001668243, Urogen Pharma Ltd

  xvar xval
0 AssetsCurrent 169,186,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 689,000
3 remainder_Assets 8,436,000
4 LiabilitiesCurrent 31,212,000
5 LiabilitiesNoncurrent 99,395,000
6 remainder_Liabilities 112,916,000
7 CostOfGoodsAndServicesSold 10,698,778
8 SellingGeneralAndAdministrativeExpense 101,696,102
9 ResearchAndDevelopmentExpense 45,993,732
10 remainder_Expenses 37,943,748
11 remainder_Revenues 124,269,946
12 remainder_NetIncome 3,583,401
13 remainder_ComprehensiveNetIncome 108,941
  yvar yval
0 Assets 178,311,000
1 Liabilities 243,523,000
2 Expenses 196,332,360
3 Revenues 124,269,946
4 StockholdersEquity -65,212,000
5 NetIncome -68,479,013
6 ComprehensiveNetIncome -68,424,542
7 BaseVar 373,064,324
8 EconomicCapitalRatiobeforeLimitedLiability -0.998
9 EconomicCapitalRatio 1.30

Edgar->Model Mapping

Feature Distribution

Change over Time